Yifang Bio: 161 million restricted shares will be listed and traded on the market on January 26, 2026.

Yifang Biotechnology announced that the restricted shares to be listed this time are part of the first public offering of restricted shares, with a total of 160,715,196 shares, accounting for 27.79% of the company's total share capital, and will be listed and traded from January 26, 2026. From the formation of the restricted shares to the date of the announcement disclosure, the company's total share capital increased from 575 million shares to 578 million shares due to the incentive plan. In addition, the company's controlling shareholders, actual controllers, directors and senior executives have made commitments to lock up their shares. The sponsor believes that the listing of restricted shares this time meets the requirements of relevant regulations and has no objections.